Re: Albuminuria
|
5
|
Resverlogix Corp.
|
Dec 02, 2019 04:55PM
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
5
|
Resverlogix Corp.
|
Dec 02, 2019 04:52PM
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
5
|
Resverlogix Corp.
|
Dec 02, 2019 04:42PM
|
Re: Looking for clues:
|
3
|
Resverlogix Corp.
|
Dec 01, 2019 05:11PM
|
Re: Looking for clues:
|
3
|
Resverlogix Corp.
|
Nov 30, 2019 03:57PM
|
Re: Looking for clues:
|
7
|
Resverlogix Corp.
|
Nov 30, 2019 03:45PM
|
Re: eGFR data question from IR
|
5
|
Resverlogix Corp.
|
Nov 28, 2019 08:22AM
|
Re: What population would our CD drug cover,...?
|
1
|
Resverlogix Corp.
|
Nov 27, 2019 12:55PM
|
Re: Warrants conversion!
|
2
|
Resverlogix Corp.
|
Nov 27, 2019 11:14AM
|
Re: Warrants conversion!
|
3
|
Resverlogix Corp.
|
Nov 27, 2019 11:10AM
|
Re: Warrants conversion!
|
3
|
Resverlogix Corp.
|
Nov 27, 2019 11:08AM
|
Re: Warrants conversion!
|
7
|
Resverlogix Corp.
|
Nov 27, 2019 11:04AM
|
Re: What population would our CD drug cover,...?
|
5
|
Resverlogix Corp.
|
Nov 27, 2019 09:26AM
|
Re: Congestive heart failure
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 07:04PM
|
Re: Congestive heart failure
|
7
|
Resverlogix Corp.
|
Nov 25, 2019 04:26PM
|
Re: Useful review on epigenetics and CKD for the scientists
|
5
|
Resverlogix Corp.
|
Nov 25, 2019 10:25AM
|
Useful review on epigenetics and CKD for the scientists
|
4
|
Resverlogix Corp.
|
Nov 25, 2019 09:22AM
|
Re: eGFR and Cognition?
|
5
|
Resverlogix Corp.
|
Nov 25, 2019 09:17AM
|
Re: A fair and optimistic write up on BETonMACE
|
6
|
Resverlogix Corp.
|
Nov 25, 2019 09:01AM
|
Re: A fair and optimistic write up on BETonMACE
|
4
|
Resverlogix Corp.
|
Nov 23, 2019 02:02PM
|